Lataa...
A patent review of the ubiquitin ligase system: 2015-2018
INTRODUCTION: Ubiquitin-Proteasome System (UPS) has been validated as a novel anticancer drug target in the past 20 years. The UPS contains two distinct steps: ubiquitination of a substrate protein by ubiquitin activating enzyme (E1), ubiquitin conjugating enzyme (E2), and ubiquitin ligase (E3), and...
Tallennettuna:
| Julkaisussa: | Expert Opin Ther Pat |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6398165/ https://ncbi.nlm.nih.gov/pubmed/30449221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2018.1549229 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|